Schonfeld Strategic Advisors LLC Ngm Biopharmaceuticals Inc Transaction History

Schonfeld Strategic Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.72 - $5.4 $74,028 - $107,460	-19,900 Reduced 64.4%	11,000 $44,000
Q4 2022 Feb 14, 2023	SELL	$3.41 - $12.93 $141,453 - $536,362	-41,482 Reduced 57.31%	30,900 $155,000
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $911,289 - $1.28 Million	72,382 New	72,382 $946,000
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $189,197 - $254,820	-13,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $236,462 - $301,674	13,700 New	13,700 $243,000
Q3 2021 Nov 16, 2021	SELL	$20.15 - $26.19 $609,597 - $792,326	-30,253 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $455,610 - $908,497	30,253 New	30,253 $597,000
Q3 2019 Nov 14, 2019	SELL	$13.09 - $18.19 $719,950 - $1 Million	-55,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $690,800 - $913,000	55,000 New	55,000 $805,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.